. 2023 Jan 6;18(1):e0279928. doi: 10.1371/journal.pone.0279928

Table 8. Top 20 significant AKI-correlated medications for two subgroups.

GFR<90 Group		GFR≥ 90 Group
Medication	Pearson Coefficient	Medication	Pearson Coefficient
Furosemide^*	0.156417	Furosemide^*	0.157797
Heparin^*	0.151747	Heparin^*	0.14804
Vancomycin^*	0.144074	Potassium Chloride^*	0.132135
Norepinephrine^*	0.136063	Propofol^*	0.12224
Potassium Chloride^*	0.130368	Vancomycin^*	0.122034
Propofol^*	0.130135	Norepinephrine^*	0.116064
Insulin^*	0.122824	Albumin^*	0.112499
Calcium Chloride^*	0.114971	Nystatin^*	0.105866
Albumin^*	0.110996	Piperacillin/Tazobactam Dextrose^*	0.100413
Vasopressin^*	0.110125	Quetiapine^*	0.091413
Midazolam^**	0.105243	Fentanyl^*	0.091391
Piperacillin/Tazobactam Dextrose^*	0.103455	Cefepime^*	0.090986
Cefepime^*	0.101895	Lidocaine^***	0.089679
Fentanyl^*	0.100948	Levofloxacin/Dext^*	0.089573
Nystatin^*	0.100707	Insulin^*	0.088559
Meropenem^^	0.097692	Calcium Chloride^*	0.08819
Levofloxacin Dextrose^*	0.097596	Sodium Chloride	0.086553
Quetiapine^*	0.0957	Milrinone	0.086109
Epinephrine	0.092968	Vasopressin^*	0.084579
Metoprolol^**	0.091587	Metronidazole	0.084005

* Meications prescribed in both subgroups.

** Medications mostly used among those with chronic kidney disease with GFR<90 ml/min/1.73 m².

*** Medications mostly used among those with chronic kidney disease with GFR≥90 ml/min/1.73 m².